About Oncotelic

About company

Oncotelic Inc. operates as a cancer immunotherapy company. The Company engaged in developing a unique TGF-b antisense therapy which has demonstrated the ability to break immune tolerance in mid-stage clinical trials for the treatment of glioblastoma and pancreatic cancer. Oncotelic serves customers in the United States.